Application 761416

Type
BLA
Sponsor
JAZZ PHARMS

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761416Ziiherazanidatamab-hrii351(a)Rx2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZIIHERAZANIDATAMAB-HRIIINJECTABLE;INJECTION300MGNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZIIHERAZANIDATAMAB-HRIIJazz Pharmaceuticals, Inc.ae5d9425-fae5-4541-a158-1509983433482025-07-01Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761416

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80557ORIG 2024-12-12
80553ORIG 2024-12-11
80261ORIG 2024-11-21